Progress towards the Development of a Universal Influenza Vaccine

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice

(2022) Carly M. Bliss et al.   MOLECULAR THERAPY

Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin

(2021) Bo Ryoung Park et al.   Scientific Reports

Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses

(2021) James D. Allen et al.   Scientific Reports

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

(2021) Saghi Nooraei et al.   JOURNAL OF NANOBIOTECHNOLOGY

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

(2021) Linde Schoenmaker et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The dawn of mRNA vaccines: The COVID-19 case

(2021) Rein Verbeke et al.   JOURNAL OF CONTROLLED RELEASE

Quadrivalent influenza nanoparticle vaccines induce broad protection

(2021) Seyhan Boyoglu-Barnum et al.   NATURE

Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine

(2021) Brianna L. Bullard et al.   Vaccines

Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice

(2021) Chia-Yun Lo et al.   VACCINE

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

(2021) Traci L. Bricker et al.   Cell Reports

Future considerations for the mRNA-lipid nanoparticle vaccine platform

(2021) Botond Z Igyártó et al.   Current Opinion in Virology

Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection

(2021) Ying Huang et al.   Vaccines

Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019

(2021) Rachel Holstein et al.   ANNALS OF INTERNAL MEDICINE

Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children

(2021) Samantha M Olson et al.   CLINICAL INFECTIOUS DISEASES

Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection

(2021) Anna A. Zykova et al.   Nanomedicine-Nanotechnology Biology and Medicine

Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics

(2020) Olivia A. Vogel et al.   Frontiers in Microbiology

Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies

(2020) Michael Lim et al.   Pharmaceutics

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

(2020) Alec W. Freyn et al.   MOLECULAR THERAPY

Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study

(2020) Olga Pleguezuelos et al.   npj Vaccines

Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens

(2020) Anna Kirsteina et al.   Vaccines

Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach

(2020) Richa Bhatnager et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Engineered Nanoparticle Applications for Recombinant Influenza Vaccines

(2020) Zachary R Sia et al.   MOLECULAR PHARMACEUTICS

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

(2020) Neeltje van Doremalen et al.   NATURE

Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection

(2020) Honglei Sun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus

(2020) Shuang Li et al.   IMMUNOLOGICAL INVESTIGATIONS

The peptide vaccine of the future

(2020) Annika Nelde et al.   MOLECULAR & CELLULAR PROTEOMICS

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

(2020) Raffael Nachbagauer et al.   NATURE MEDICINE

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

(2019) Masaru Kanekiyo et al.   NATURE IMMUNOLOGY

Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus

(2019) Myung Hee Kim et al.   ANTIVIRAL RESEARCH

Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach

(2019) Weina Sun et al.   JOURNAL OF VIROLOGY

Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults

(2019) Hannah E Maier et al.   CLINICAL INFECTIOUS DISEASES

Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza—U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET)

(2019) Christopher A Czaja et al.   Open Forum Infectious Diseases

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice

(2019) Guha Asthagiri Arunkumar et al.   VACCINE

A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine

(2019) Xiaoqin Gou et al.   Human Vaccines & Immunotherapeutics

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge

(2019) Meagan McMahon et al.   Frontiers in Immunology

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018–2019 Season

(2019) Brendan Flannery et al.   JOURNAL OF INFECTIOUS DISEASES

A Computationally Optimized Broadly Reactive Antigen Subtype–Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin

(2019) Giuseppe A. Sautto et al.   JOURNAL OF IMMUNOLOGY

Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice

(2019) Ye Wang et al.   Advanced Healthcare Materials

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

(2018) Yao-Qing Chen et al.   CELL

Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk

(2018) Charles J. Russell et al.   TRENDS IN MICROBIOLOGY

Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine

(2018) Jian Yan et al.   VACCINE

Economic burden of seasonal influenza in the United States

(2018) Wayan C.W.S. Putri et al.   VACCINE

Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence

(2018) Xianqiang Ping et al.   VACCINE

Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic

(2018) Alain Gagnon et al.   mBio

Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice

(2018) Yuan Luo et al.   Scientific Reports

Structural and Functional Motifs in Influenza Virus RNAs

(2018) Damien Ferhadian et al.   Frontiers in Microbiology

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs

(2018) Santosh Dhakal et al.   Frontiers in Immunology

Novel Platforms for the Development of a Universal Influenza Vaccine

(2018) Arun Kumar et al.   Frontiers in Immunology

Clinical and immunological characteristics of human infections with H5N6 avian influenza virus

(2018) Yuhai Bi et al.   CLINICAL INFECTIOUS DISEASES

A Synthetic Micro-Consensus DNA Vaccine Generates Comprehensive Influenza A H3N2 Immunity and Protects Mice Against Lethal Challenge by Multiple H3N2 Viruses

(2018) Sarah T.C. Elliott et al.   HUMAN GENE THERAPY

A newly developed tetraplex real time RT-PCR for simultaneous screening of influenza virus types A, B, C and D

(2018) D Henritzi et al.   Influenza and Other Respiratory Viruses

Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine

(2018) Liudmila M. Tsybalova et al.   PLoS One

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

(2018) Norbert Pardi et al.   Nature Communications

DNA Vaccines—How Far From Clinical Use?

(2018) Dominika Hobernik et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens

(2018) Seth J Zost et al.   JOURNAL OF INFECTIOUS DISEASES

A Perspective on Nanoparticle Universal Influenza Vaccines

(2018) Lei Deng et al.   ACS Infectious Diseases

Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses

(2017) Donald M. Carter et al.   JOURNAL OF VIROLOGY

Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies

(2017) Ram P. Kamal et al.   JOURNAL OF VIROLOGY

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

(2017) Megan E. Ermler et al.   JOURNAL OF VIROLOGY

Chimpanzee Adenovirus Vector Ebola Vaccine

(2017) Julie E. Ledgerwood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes

(2017) Gale Smith et al.   VACCINE

M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza

(2017) Yasuko Hatta et al.   VACCINE

Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes

(2017) Mohammed Y.E. Chowdhury et al.   VETERINARY MICROBIOLOGY

Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity

(2017) John J. Suschak et al.   Human Vaccines & Immunotherapeutics

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

(2017) Raffael Nachbagauer et al.   npj Vaccines

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses

(2017) Ahmed O. Hassan et al.   PLoS One

Micro- and nanoparticulates for DNA vaccine delivery

(2016) Eric Farris et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Investigational hemagglutinin-targeted influenza virus inhibitors

(2016) Li-Yan Zeng et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Recombinant hemagglutinin influenza vaccine provides broader spectrum protection

(2016) Lisa M. Dunkle et al.   Expert Review of Vaccines

M2-based influenza vaccines: recent advances and clinical potential

(2016) Annasaheb Kolpe et al.   Expert Review of Vaccines

Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

(2016) David J. DiLillo et al.   JOURNAL OF CLINICAL INVESTIGATION

Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses

(2016) Donald M. Carter et al.   JOURNAL OF VIROLOGY

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

(2016) Diletta Magini et al.   PLoS One

Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges

(2016) Heidrun Steinle et al.   STEM CELLS

M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice

(2016) Sally Sarawar et al.   VACCINE

Polymers for DNA Vaccine Delivery

(2016) Mingming Zhang et al.   ACS Biomaterials-Science & Engineering

Polymers for DNA Vaccine Delivery

(2016) Mingming Zhang et al.   ACS Biomaterials Science & Engineering

Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs

(2016) Jagadish Hiremath et al.   PLoS One

A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans

(2015) Olga Pleguezuelos et al.   Clinical and Vaccine Immunology

Clinical potential of electroporation for gene therapy and DNA vaccine delivery

(2015) Laure Lambricht et al.   Expert Opinion on Drug Delivery

Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection

(2015) Min-Chul Kim et al.   JOURNAL OF CONTROLLED RELEASE

Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection

(2015) Arnold S. Monto et al.   JOURNAL OF INFECTIOUS DISEASES

Adenoviral vectors as novel vaccines for influenza

(2015) Lynda Coughlan et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus

(2015) Louis M. Schwartzman et al.   mBio

The potential of nanoparticles for the immunization against viral infections

(2015) Viktoriya Sokolova et al.   Journal of Materials Chemistry B

Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines

(2015) Yu-Na Lee et al.   Immune Network

Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin

(2015) Liudmila A. Stepanova et al.   PLoS One

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins

(2014) Kristy Blanchfield et al.   Influenza and Other Respiratory Viruses

Epitope-based approaches to a universal influenza vaccine

(2014) Tanya Gottlieb et al.   JOURNAL OF AUTOIMMUNITY

Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene

(2014) A. Kamlangdee et al.   JOURNAL OF VIROLOGY

At the centre: influenza A virus ribonucleoproteins

(2014) Amie J. Eisfeld et al.   NATURE REVIEWS MICROBIOLOGY

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

(2014) Annett Hessel et al.   PLoS One

Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

(2014) Danuta M. Skowronski et al.   PLoS One

The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors

(2014) William E. O’Gorman et al.   VACCINE

Options and Obstacles for Designing a Universal Influenza Vaccine

(2014) Yo Jang et al.   Viruses-Basel

In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen

(2014) Teddy Wohlbold et al.   Viruses-Basel

Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family

(2014) B. M. Hause et al.   mBio

Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages

(2014) Dagmar A Kuhn et al.   Beilstein Journal of Nanotechnology

Universal anti-neuraminidase antibody inhibiting all influenza A subtypes

(2013) Tracey M. Doyle et al.   ANTIVIRAL RESEARCH

Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses

(2013) Emma Grant et al.   IMMUNOLOGY AND CELL BIOLOGY

Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain

(2013) D. Eggink et al.   JOURNAL OF VIROLOGY

Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses

(2013) I. Margine et al.   JOURNAL OF VIROLOGY

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

(2013) F. Krammer et al.   JOURNAL OF VIROLOGY

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

(2013) Masaru Kanekiyo et al.   NATURE

Characterization of H7N9 influenza A viruses isolated from humans

(2013) Tokiko Watanabe et al.   NATURE

Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection

(2013) So-Hee Kim et al.   PLoS One

Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses

(2013) R. A. Medina et al.   Science Translational Medicine

Nanoparticle vaccines

(2013) Liang Zhao et al.   VACCINE

Chitosan-based delivery systems for mucosal vaccines

(2012) Inderjit Jabbal-Gill et al.   Expert Opinion on Drug Delivery

Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine

(2012) Jacob Atsmon et al.   JOURNAL OF CLINICAL IMMUNOLOGY

A Computationally Optimized Hemagglutinin Virus-Like Particle Vaccine Elicits Broadly Reactive Antibodies that Protect Nonhuman Primates from H5N1 Infection

(2012) Brendan M. Giles et al.   JOURNAL OF INFECTIOUS DISEASES

Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes

(2012) R. Hai et al.   JOURNAL OF VIROLOGY

Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

(2012) Min-Chul Kim et al.   MOLECULAR THERAPY

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets

(2012) Masaki Imai et al.   NATURE

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

(2012) Tom M Wilkinson et al.   NATURE MEDICINE

Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets

(2012) S. Herfst et al.   SCIENCE

Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man

(2012) E. Barnes et al.   Science Translational Medicine

Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)

(2011) Natalie J. Carter et al.   DRUGS

Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

(2011) Mark R. Soboleski et al.   PLoS One

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

(2011) D. C. Ekiert et al.   SCIENCE

Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine

(2011) Robert L. Atmar et al.   VACCINE

A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets

(2011) Brendan M. Giles et al.   VACCINE

Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target

(2010) Neetu Singh et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

DNA vaccines: an historical perspective and view to the future

(2010) Margaret A. Liu   IMMUNOLOGICAL REVIEWS

A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge

(2010) Dongming Zhou et al.   MOLECULAR THERAPY

Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses

(2010) Graeme E. Price et al.   PLoS One

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

(2010) T. T. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design

(2010) C.-J. Wei et al.   Science Translational Medicine

Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences

(2010) Caroline Gravel et al.   VACCINE

Influenza A viruses: why focusing on M2e-based universal vaccines

(2010) Seyyed Mahmoud Ebrahimi et al.   VIRUS GENES

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments

(2009) Michael Schotsaert et al.   Expert Review of Vaccines

Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes

(2009) Lorena E Brown et al.   IMMUNOLOGY AND CELL BIOLOGY

A universal epitope-based influenza vaccine and its efficacy against H5N1

(2009) Y. Adar et al.   VACCINE

A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine

(2009) Rebecca J. Cox et al.   VACCINE

M2e-based universal influenza A vaccine

(2009) Walter Fiers et al.   VACCINE

Identification of Amino Acids in HA and PB2 Critical for the Transmission of H5N1 Avian Influenza Viruses in a Mammalian Host

(2009) Yuwei Gao et al.   PLoS Pathogens

Nanoparticles target distinct dendritic cell populations according to their size

(2008) Vania Manolova et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans

(2008) E. Assarsson et al.   JOURNAL OF VIROLOGY

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

(2008) Mark Throsby et al.   PLoS One

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

(2008) M.-W. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The biology of influenza viruses

(2008) Nicole M. Bouvier et al.   VACCINE